BCM
CHAQ.WS

Beryl Capital Management’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Beryl Capital Management’s Portfolio CHAQ.WS Stock Details CHAQ.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-109,219
Closed -$108K – 338
2020
Q4 		$108K Hold
109,219
– – 0.02% 225
2020
Q3 		$79K Buy
+109,219
New +$76.4K 0.01% 94

Other funds holding CHAQ.WS

BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return

Beryl Capital Management's CHAQ.WS Position: Q1 2021 in Review

Beryl Capital Management sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q1 2021, closing a stake of 109,219 shares — an estimated $108K sold.

Beryl Capital Management first reported a position in CHAQ.WS in Q3 2020 and held it in 2 quarters. The position peaked at $108K in Q4 2020. 22 funds tracked by Wall St. Rank hold CHAQ.WS as of Q1 2021.

  • Beryl Capital Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q1 2021 after selling out during the quarter.
  • Beryl Capital Management sold 109,219 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q1 2021, an estimated $108K.
  • Beryl Capital Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q3 2020 and held it in 2 quarters.
  • Beryl Capital Management's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $108K in Q4 2020.
  • 22 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q1 2021.

Based on Beryl Capital Management's 13F filing for Q1 2021, filed 17 May 2021.